IndiaOne Finance - Company Dashboard

Governance Classic Home

Transchem LtdPharmaceuticalsINE019B01010

Valuation

Market Cap₹489.60 Cr

TTM PE72.86x

Forward PE60.85x

PEG0.71

Book Value₹312.50

P/B1.28x

TTM EPS₹5.49

Fwd EPS₹6.57

TTM Revenue₹0.00 Cr

TTM PAT₹6.72 Cr

TTM EBITDA₹-4.07 Cr

TTM EBIT₹-4.12 Cr

Last Qtr PAT₹2.09 Cr

Last Qtr EBITDA₹-0.70 Cr

Last Qtr EBIT₹-0.75 Cr

Profitability

ROE—

ROCE—

TTM NPM—

Curr OPM0.00%

Last OPM0.00%

Curr NPM—

Last NPM—

Curr EPS₹2.79

Last EPS₹1.71

Balance sheet

Equity—

Reserve—

Total Debt₹0.00 Cr

D/E—

Interest %0.29%

Curr Interest₹0.01 Cr

Price / range

Close₹400.00

vs 52W High-1.96%

vs 52W Low+590.25%

MA50—

MA200—

Returns

1D+1.55%

1W+4.95%

1M+22.62%

3M+25.10%

6M+158.31%

1Y+489.62%

2Y+842.51%

3Y+1570.15%

5Y+1747.58%

Diwali+114.19%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1868.90	₹4.48L Cr	150.72	3.58%
DIVISLAB	9410.50	₹2.50L Cr	84.94	17.55%
TORNTPHARM	4970.00	₹1.89L Cr	80.92	25.43%
ZYDUSLIFE	1161.00	₹1.16L Cr	33.24	12.96%
CIPLA	1386.10	₹1.12L Cr	36.42	8.93%
LAURUSLABS	2017.50	₹1.09L Cr	124.85	16.46%
MANKIND	2437.80	₹1.01L Cr	46.14	13.38%
DRREDDY	1198.30	₹1.00L Cr	150.35	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	0	0	0	0	0	0
Other Income	5.11	3.70	2.25	1.68	1.64	9.26
Total Income	5.11+211.6%	3.70	2.25	1.68	1.64	9.26
Interest	0.01	0	0	0	0	0
Expenditure	-0.76-280.0%	-1.31	-1.31	-0.75	-0.20	-3.65
PBDT	0	0	0	0	0	0
EBITDA	-0.70-250.0%	-1.31	-1.31	-0.75	-0.20	-3.64
Depreciation	-0.05	0	0	0	0	-0.01
EBIT	-0.75-275.0%	-1.31	-1.31	-0.75	-0.20	-3.65
PBT	4.35+222.2%	2.39	0.94	0.93	1.35	5.61
Tax	-0.93	-0.29	-0.41	-0.25	-0.30	-1.31
Equity	0	0	0	0	0	0
OPM	0.00	0.00	0.00	0.00	0.00	61.00
Net Profit	3.42+245.5%	2.09	0.53	0.68	0.99	4.30
NPM	0.00	0.00	0.00	0.00	0.00	46.00
EPS	2.79	1.71	0.43	0.56	0	3.51

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	0-100.0%	2.63+541.5%	0.41	0	0	0
Other Income	9.26	8.53	7.40	4.25	6.66	26.83
Total Income	9.26-17.0%	11.16+42.9%	7.81+83.8%	4.25-36.2%	6.66-75.2%	26.83
Expenditure	-3.65+11.0%	-4.10-90.7%	-2.15-23.6%	-1.74+36.7%	-2.75-33.5%	-2.06
Interest	0	0	0	0	0	0
PBDT	0	0	0	0	0	0
EBITDA	-3.64-149.3%	-1.46+15.6%	-1.73+0.0%	-1.73+36.9%	-2.74-41.2%	-1.94
Depreciation	-0.01	-0.01	-0.01	-0.01	-0.01	-0.12
EBIT	-3.65-148.3%	-1.47+15.5%	-1.74+0.0%	-1.74+36.7%	-2.75-33.5%	-2.06
PBT	5.61-20.5%	7.06+25.0%	5.65+126.0%	2.50-36.1%	3.91-84.2%	24.77
Tax	-1.31	-1.80	-1.45	-1.27	-1.04	-0.62
Equity	0	0	0	0	0	0
OPM (%)	61.00	63.00	72.00	59.00	59.00	92.00
Net Profit	4.30-17.8%	5.23+24.5%	4.20+238.7%	1.24-56.8%	2.87-88.1%	24.15
NPM (%)	46.00	47.00	54.00	29.00	43.00	90.00
EPS (Rs)	3.51-17.8%	4.27+24.5%	3.43+239.6%	1.01-56.8%	2.34-88.1%	19.73
CEPS	3.51	4.27	3.43	1.01	2.34	19.73

No financial result data.

Yearly results

Last 6 financial years · YoY % vs previous FY

No yearly result data.

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split